{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:49:53Z","timestamp":1791352193307,"version":"4.3.1"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Autoimmune hepatitis (AIH) can complicate paediatric intestinal diseases, but practical tools for early screening and risk stratification are limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study included 346 children with intestinal diseases treated at a tertiary centre from 2015 to 2023, including 68 with concurrent AIH and 278 without AIH. Baseline clinical and laboratory variables measured at the initial gastroenterology evaluation were analysed. Candidate variables were selected using least absolute shrinkage and selection operator logistic regression and entered into multivariable logistic regression to construct a nomogram-based screening model. Model performance was assessed using receiver operating characteristic curve analysis, calibration metrics, bootstrap internal validation, and decision curve analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Eight variables associated with concurrent AIH were included: disease duration \u226512\u202fmonths, C-reactive protein \u226515\u202fmg\/L, immunoglobulin G \u226516\u202fg\/L, erythrocyte sedimentation rate \u226525\u202fmm\/h, antinuclear antibody positivity, corticosteroid use, pancolitis, and family history of autoimmune disease. The model showed an apparent area under the curve (AUC) of 0.974 and a bootstrap-corrected AUC of 0.893. Calibration was acceptable, with a slope of 0.87, intercept of \u22120.03, Brier score of 0.098, and a non-significant Hosmer\u2013Lemeshow test (\n                      <jats:italic>p<\/jats:italic>\n                      =\u202f0.398). Decision curve analysis indicated a greater net benefit for referral-oriented screening than single-predictor or default strategies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The nomogram may help screen children with intestinal diseases who warrant early hepatological evaluation for concurrent AIH. It should not be used as a standalone diagnostic instrument, and external validation is required before routine clinical use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1861363","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:50:44Z","timestamp":1791348644000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and internal validation of a nomogram-based screening tool for concurrent autoimmune hepatitis in children with intestinal diseases: a retrospective cohort study"],"prefix":"10.3389","volume":"13","author":[{"given":"YanFang","family":"Hou","sequence":"first","affiliation":[{"name":"Department of Pediatric Ward One, Kaifeng Central Hospital","place":["Kaifeng, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"18017","DOI":"10.1038\/nrdp.2018.17","article-title":"Autoimmune hepatitis","volume":"4","author":"Mieli-Vergani","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20-year experience","volume":"25","author":"Gregorio","year":"1997","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cld.2015.08.002","article-title":"The immunogenetics of autoimmune cholestasis","volume":"20","author":"Trivedi","year":"2014","journal-title":"Clin Liver Dis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.5114\/ceh.2019.87632","article-title":"Hepatobiliary manifestations of inflammatory bowel disease in children","volume":"5","author":"Kucharska","year":"2019","journal-title":"Clin Exp Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut-liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/alcalc\/agx025","article-title":"Gut-liver axis and sterile signals in the development of alcoholic liver disease","volume":"52","author":"Szabo","year":"2017","journal-title":"Alcohol Alcohol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/mpg.0000000000001125","article-title":"Clinical characteristics and prognosis in children and adolescents with autoimmune hepatitis and overlap syndrome","volume":"63","author":"Rodrigues","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/hep.29204","article-title":"The natural history of primary sclerosing cholangitis in 781 children: a multicenter, international collaboration","volume":"66","author":"Deneau","year":"2017","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jaut.2013.08.004","article-title":"Autoimmune hepatitis: contrasts and comparisons in children and adults\u2014a comprehensive review","volume":"46","author":"Floreani","year":"2013","journal-title":"J Autoimmun"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1097\/MIB.0000000000000558","article-title":"Abnormal liver biochemistry is common in pediatric inflammatory bowel disease: prevalence and associations","volume":"21","author":"Valentino","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.rce.2016.04.003","article-title":"Autoimmune hepatitis: from mechanisms to therapy","volume":"216","author":"Liberal","year":"2016","journal-title":"Rev Clin Esp (Barc)"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","article-title":"How to build and interpret a nomogram for cancer prognosis","volume":"26","author":"Iasonos","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","article-title":"Nomograms in oncology: more than meets the eye","volume":"16","author":"Balachandran","year":"2015","journal-title":"Lancet Oncol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression shrinkage and selection via the LASSO","volume":"58","author":"Tibshirani","year":"1996","journal-title":"J R Stat Soc B"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","article-title":"Assessing the performance of prediction models: a framework for some traditional and novel measures","volume":"21","author":"Steyerberg","year":"2010","journal-title":"Epidemiology"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Mak"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-16399-0","volume-title":"Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating","author":"Steyerberg","year":"2019"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","article-title":"Mice: multivariate imputation by chained equations in R","volume":"45","author":"van Buuren","year":"2011","journal-title":"J Stat Softw"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1046\/j.1440-1746.2001.02615.x","article-title":"Long-term outcome of autoimmune hepatitis in children and adolescents: a 20-year experience from a single center","volume":"16","author":"Saadah","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.cgh.2019.08.048","article-title":"Primary sclerosing cholangitis in children with inflammatory bowel diseases is associated with milder clinical activity but more frequent subclinical inflammation and growth impairment","volume":"18","author":"Ricciuto","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrgastro.2016.169","article-title":"The intestinal epithelial barrier: a therapeutic target?","volume":"14","author":"Odenwald","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1053\/j.gastro.2014.04.022","article-title":"Genome-wide association study identifies variants associated with autoimmune hepatitis type 1","volume":"147","author":"de Boer","year":"2014","journal-title":"Gastroenterology"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.cld.2018.06.005","article-title":"Autoimmune hepatitis, sclerosing cholangitis, and autoimmune sclerosing cholangitis or overlap syndrome","volume":"22","author":"Kerkar","year":"2018","journal-title":"Clin Liver Dis"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/sim.7992","article-title":"Minimum sample size for developing a multivariable prediction model: PART II\u2014binary and time-to-event outcomes","volume":"38","author":"Riley","year":"2019","journal-title":"Stat Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"g7594","DOI":"10.1136\/bmj.g7594","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"350","author":"Collins","year":"2015","journal-title":"BMJ"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"6030","DOI":"10.3748\/wjg.v23.i33.6030","article-title":"Autoimmune hepatitis: standard treatment and systematic review of alternative treatments","volume":"23","author":"Terziroli Beretta-Piccoli","year":"2017","journal-title":"World J Gastroenterol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.7326\/M18-1376","article-title":"PROBAST: a tool to assess risk of bias and applicability of prediction model studies","volume":"170","author":"Wolff","year":"2019","journal-title":"Ann Intern Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1861363\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:50:56Z","timestamp":1791348656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1861363\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":31,"alternative-id":["10.3389\/fmed.2026.1861363"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1861363","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"article-number":"1861363"}}